The effects of roflumilast, a phosphodiesterase type-4 inhibitor, on EEG biomarkers in schizophrenia: A randomised controlled trial

James Gilleen, Judith Nottage, Farah Yakub, Sarah Kerins, Lorena Valdearenas, Tolga Uz, Gez Lahu, Max Tsai, Frank Ogrinc, Steve Williams, Dominic Ffytche, Mitul Mehta, Sukhi Shergill

Research output: Contribution to journalArticlepeer-review

93 Downloads (Pure)

Search results